TY - JOUR
T1 - Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults
AU - Porsbjerg, Celeste
AU - Ulrik, Charlotte
AU - Skjold, Tina
AU - Backer, Vibeke
AU - Laerum, Birger
AU - Lehman, Sverre
AU - Janson, Crister
AU - Sandstrøm, Thomas
AU - Bjermer, Leif
AU - Dahlen, Barbro
AU - Lundbäck, Bo
AU - Ludviksdottir, Dora
AU - Björnsdóttir, Unnur
AU - Altraja, Alan
AU - Lehtimäki, Lauri
AU - Kauppi, Paula
AU - Karjalainen, Jussi
AU - Kankaanranta, Hannu
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care.
AB - Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care.
U2 - 10.1080/20018525.2018.1440868
DO - 10.1080/20018525.2018.1440868
M3 - Review
C2 - 29535852
SN - 2001-8525
VL - 5
JO - European Clinical Respiratory Journal
JF - European Clinical Respiratory Journal
IS - 1
M1 - 1440868
ER -